| 000 | 01875 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250511200648.0 | ||
| 264 | 0 | _c19911230 | |
| 008 | 199112s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(91)90459-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeNinno, M P | |
| 245 | 0 | 0 |
_aA68930: a potent agonist selective for the dopamine D1 receptor. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cJun 1991 |
||
| 300 |
_a209-19 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenylyl Cyclases _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzazepines _xpharmacology |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCarps |
| 650 | 0 | 4 |
_aChromans _xmetabolism |
| 650 | 0 | 4 |
_aDeoxyglucose _xmetabolism |
| 650 | 0 | 4 |
_aDopamine Agents _xmetabolism |
| 650 | 0 | 4 |
_aHaloperidol _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aOxidopamine _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, beta _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 | _aReceptors, Dopamine D1 |
| 650 | 0 | 4 |
_aSeizures _xchemically induced |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aSchoenleber, R | |
| 700 | 1 | _aMacKenzie, R | |
| 700 | 1 | _aBritton, D R | |
| 700 | 1 | _aAsin, K E | |
| 700 | 1 | _aBriggs, C | |
| 700 | 1 | _aTrugman, J M | |
| 700 | 1 | _aAckerman, M | |
| 700 | 1 | _aArtman, L | |
| 700 | 1 | _aBednarz, L | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 199 _gno. 2 _gp. 209-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(91)90459-4 _zAvailable from publisher's website |
| 999 |
_c1689702 _d1689702 |
||